775 Stock Overview
An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.83 |
| 52 Week High | HK$1.10 |
| 52 Week Low | HK$0.32 |
| Beta | 0.38 |
| 1 Month Change | 16.90% |
| 3 Month Change | 59.62% |
| 1 Year Change | 84.44% |
| 3 Year Change | 27.69% |
| 5 Year Change | -16.16% |
| Change since IPO | -61.40% |
Recent News & Updates
Recent updates
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Apr 14
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Jan 28CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Oct 04There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise
May 03CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think
Apr 25CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky
Mar 26Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly
Sep 27Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?
Sep 16Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)
Aug 21These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively
Apr 14CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry
Mar 18If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns
Feb 01
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?
Jan 04CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet
Dec 09We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide
Nov 18Shareholder Returns
| 775 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | -2.4% | -6.4% | 2.1% |
| 1Y | 84.4% | 38.8% | 12.6% |
Return vs Industry: 775 exceeded the Hong Kong Biotechs industry which returned 38.8% over the past year.
Return vs Market: 775 exceeded the Hong Kong Market which returned 12.6% over the past year.
Price Volatility
| 775 volatility | |
|---|---|
| 775 Average Weekly Movement | 13.4% |
| Biotechs Industry Average Movement | 13.7% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in HK Market | 15.5% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 775's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 775's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 2,033 | Lance Richard Yuen | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| 775 fundamental statistics | |
|---|---|
| Market cap | HK$7.98b |
| Earnings (TTM) | -HK$126.55m |
| Revenue (TTM) | HK$5.52b |
1.4x
P/S Ratio-63.0x
P/E RatioIs 775 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 775 income statement (TTM) | |
|---|---|
| Revenue | HK$5.52b |
| Cost of Revenue | HK$3.83b |
| Gross Profit | HK$1.69b |
| Other Expenses | HK$1.82b |
| Earnings | -HK$126.55m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 30.65% |
| Net Profit Margin | -2.29% |
| Debt/Equity Ratio | 155.9% |
How did 775 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/14 17:47 |
| End of Day Share Price | 2025/05/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CK Life Sciences Int'l., (Holdings) Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jayaprabha Dhavale | Virtua Research Inc. |